Biomx IncNYSE American:PHGE
- LAST PRICE0.5447
- TODAY'S CHANGE (%)0.0529 (10.7564%)
- Bid / Lots0.5010/ 23
- Ask / Lots0.6090/ 10
- Open / Previous Close0.5700 / 0.4918
- Day Range
- 52 Week Range
- Volume87,971
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PHGE |
|---|---|---|
| 09:32 ET | 5641 | 0.57 |
| 09:37 ET | 1000 | 0.556507 |
| 09:39 ET | 200 | 0.5243 |
| 09:46 ET | 2049 | 0.5247 |
| 09:50 ET | 3978 | 0.4929 |
| 09:53 ET | 170 | 0.4929 |
| 10:04 ET | 300 | 0.52 |
| 10:08 ET | 2000 | 0.5199 |
| 10:09 ET | 100 | 0.519999 |
| 10:26 ET | 100 | 0.52 |
| 10:27 ET | 690 | 0.519999 |
| 10:38 ET | 100 | 0.52 |
| 10:51 ET | 1000 | 0.5011 |
| 11:00 ET | 100 | 0.52 |
| 11:05 ET | 100 | 0.52 |
| 11:09 ET | 2191 | 0.516712 |
| 11:14 ET | 100 | 0.52 |
| 11:25 ET | 20252 | 0.51745 |
| 11:56 ET | 100 | 0.5199 |
| 11:59 ET | 100 | 0.5199 |
| 12:15 ET | 300 | 0.5146 |
| 12:19 ET | 100 | 0.5199 |
| 12:37 ET | 100 | 0.5199 |
| 12:39 ET | 1300 | 0.5156 |
| 12:48 ET | 100 | 0.5199 |
| 12:57 ET | 1000 | 0.5099 |
| 01:09 ET | 100 | 0.5199 |
| 01:24 ET | 100 | 0.5199 |
| 01:27 ET | 541 | 0.5011 |
| 01:38 ET | 600 | 0.5198 |
| 01:42 ET | 500 | 0.5105 |
| 01:47 ET | 100 | 0.5199 |
| 02:05 ET | 100 | 0.5199 |
| 02:12 ET | 300 | 0.516 |
| 02:20 ET | 6000 | 0.513894 |
| 02:21 ET | 300 | 0.5159 |
| 02:23 ET | 100 | 0.516 |
| 02:34 ET | 960 | 0.5159 |
| 02:38 ET | 1100 | 0.516 |
| 02:39 ET | 5000 | 0.516 |
| 02:41 ET | 1600 | 0.516 |
| 02:54 ET | 3764 | 0.5243 |
| 03:01 ET | 100 | 0.534751 |
| 03:03 ET | 1379 | 0.53475 |
| 03:08 ET | 5000 | 0.5347 |
| 03:44 ET | 3419 | 0.54 |
| 03:48 ET | 1100 | 0.5243 |
| 03:53 ET | 1952 | 0.5498 |
| 03:55 ET | 2563 | 0.5448 |
| 04:00 ET | 1007 | 0.5447 |
Nov 14, 2024
BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates, from 6:30AM ET on Thursday Nov 14, 2024 by Dow Jones
6:30AM ET on Thursday Nov 14, 2024 by Dow JonesPress Release: BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates, from 6:30AM ET on Thursday Nov 14, 2024 by Dow Jones
6:30AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 12, 2024
BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024, from 12:20PM ET on Tuesday Nov 12, 2024 by Dow Jones
12:20PM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biomx Inc | 9.9M | 2.1x | --- |
Nascent Biotech Inc | 10.0M | -4.8x | --- |
Mustang Bio Inc | 9.8M | -0.1x | --- |
Kiora Pharmaceuticals Inc | 10.1M | -5.6x | --- |
Apollomics Inc | 10.1M | -0.2x | --- |
Indaptus Therapeutics Inc | 10.2M | -0.6x | --- |
Company Information
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Contact Information
- Headquarters
- 708 Quince Orchard Rd, Suite 205GAITHERSBURG, MD, United States 20878
- Phone
- ---
- Fax
- 800-253-5177
Executives
- Independent Chairman of the Board
- Russell Greig
- Chief Executive Officer, Director
- Jonathan Solomon
- Chief Financial Officer
- Marina Wolfson
- Chief Development Officer
- Merav Bassan
- Chief Business Officer
- Assaf Oron
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 18.2M |
Biomx Inc does not pay a dividend. | |
Beta | 1.28 |
EPS | $0.26 |
Book Value | $0.07 |
P/E Ratio | 2.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
